CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $175M invested in Concert Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+2
Holders Change %
+2.6%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
35
Reduced
27
Closed
8
Calls
$468K
Puts
–
Net Calls
+$468K
Net Calls Change
+$674K
Top Buyers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$16.4M |
2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$8.96M |
3 |
Millennium Management
New York
|
$9.82M |
4 |
BlackRock
New York
|
$15.5M |
5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
$2.3M |